Marianne Burgard

Summary

Country: France

Publications

  1. doi request reprint Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis
    Marianne Burgard
    Laboratoire de Virologie, Hopital Necker, AP HP, Paris, France
    J Pediatr 160:60-6.e1. 2012
  2. doi request reprint Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
    Marianne Burgard
    Laboratoire de Virologie, CHU Necker Enfants Malades, AP HP, Paris, France
    AIDS 23:2165-71. 2009
  3. doi request reprint LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)
    Véronique Avettand-Fenoel
    Assistance Publique Hopitaux de Paris, CHU Necker Enfants Malades, Service de Virologie, Paris, France
    J Med Virol 81:217-23. 2009
  4. pmc Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
    Laurence Weiss
    Faculte de Medecine, Universite Paris Descartes, Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Paris, France
    PLoS ONE 5:e11659. 2010
  5. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
  6. doi request reprint In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations
    Daniel Scott-Algara
    Institut Pasteur, Unité de Régulation des Infections Rétrovirales, 25 rue du Dr Roux, Paris, France
    J Acquir Immune Defic Syndr 53:553-63. 2010
  7. ncbi request reprint Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts
    Christine Rouzioux
    Laboratoire de Virologie, Paris, France
    J Infect Dis 192:46-55. 2005
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
  9. ncbi request reprint Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study
    Cecile Goujard
    Service de Medecine Interne, Bicetre Hospital, AP HP, Le Kremlin Bicetre, Paris, France
    AIDS Res Hum Retroviruses 23:1105-13. 2007
  10. doi request reprint A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Paris, France
    J Med Virol 82:1819-28. 2010

Detail Information

Publications12

  1. doi request reprint Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis
    Marianne Burgard
    Laboratoire de Virologie, Hopital Necker, AP HP, Paris, France
    J Pediatr 160:60-6.e1. 2012
    ..To compare performance of testing for human immunodeficiency virus (HIV)-1 DNA and HIV-1 RNA for diagnosis of HIV-1 infection in infants receiving preventive antiretroviral therapy...
  2. doi request reprint Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
    Marianne Burgard
    Laboratoire de Virologie, CHU Necker Enfants Malades, AP HP, Paris, France
    AIDS 23:2165-71. 2009
    ....
  3. doi request reprint LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01)
    Véronique Avettand-Fenoel
    Assistance Publique Hopitaux de Paris, CHU Necker Enfants Malades, Service de Virologie, Paris, France
    J Med Virol 81:217-23. 2009
    ..The results were equivalent to those of HIV-RNA assay. HIV-DNA may be used even in masked primary infection in newborns whose mothers have received HAART...
  4. pmc Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
    Laurence Weiss
    Faculte de Medecine, Universite Paris Descartes, Assistance Publique Hopitaux de Paris AP HP, Hopital Europeen Georges Pompidou, Paris, France
    PLoS ONE 5:e11659. 2010
    ..However, the insufficient increase in the proportion and/or the decrease in the absolute number of Tregs result in a failure to control immune activation following TI...
  5. doi request reprint Late postnatal HIV infection in children born to HIV-1-infected mothers in a high-income country
    Pierre Frange
    Unite d immunologie, Hématologie et Rhumatologie pédiatriques, Hopital Necker, Paris, France
    AIDS 24:1771-6. 2010
    ..To evaluate the risk of late postnatal HIV-1 infection in nonbreastfed children enrolled in the French ANRS Cohort CO01 (EPF)...
  6. doi request reprint In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations
    Daniel Scott-Algara
    Institut Pasteur, Unité de Régulation des Infections Rétrovirales, 25 rue du Dr Roux, Paris, France
    J Acquir Immune Defic Syndr 53:553-63. 2010
    ..The associations between the level of infected cells and immune markers have been poorly studied, particularly in perinatally infected children...
  7. ncbi request reprint Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts
    Christine Rouzioux
    Laboratoire de Virologie, Paris, France
    J Infect Dis 192:46-55. 2005
    ....
  8. pmc Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
    Constance Delaugerre
    EA 3620 MRT, Descartes University, Paris, France
    Retrovirology 6:85. 2009
    ..Primary-HIV-1-infection in newborns that occurs under antiretroviral prophylaxis that is a high risk of drug-resistance acquisition. We examine the frequency and the mechanisms of resistance acquisition at the time of infection in newborns...
  9. ncbi request reprint Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study
    Cecile Goujard
    Service de Medecine Interne, Bicetre Hospital, AP HP, Le Kremlin Bicetre, Paris, France
    AIDS Res Hum Retroviruses 23:1105-13. 2007
    ..Treatment interruption is safe in patients treated early after primary HIV infection. On the basis of this pilot study, HIV immunizations and interleukin-2 appear to have no supplementary benefit...
  10. doi request reprint A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir
    Christophe Piketty
    AP HP, Department of Clinical Immunology, Georges Pompidou European Hospital, Paris, France
    J Med Virol 82:1819-28. 2010
    ..A high PBMC HIV DNA level at TI was a strong predictor for more rapid treatment resumption...
  11. ncbi request reprint Characteristics of HIV-infected children recently diagnosed in Paris, France
    Eugenia Macassa
    Unité d Immunologie Hématologie Pédiatriques, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015, Paris, France
    Eur J Pediatr 165:684-7. 2006
    ..HIV-1 infection should be taken into consideration in children born in countries with a high prevalence of HIV, even if they have been living in France for several years and present no symptoms...
  12. ncbi request reprint Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level
    Jean Paul Viard
    Service d immunologie clinique, Universite Rene Descartes, Faculte de Medecine Necker Enfants Malades, Paris, France
    AIDS 18:45-9. 2004
    ..e., constant plasma HIV-1 RNA load suppression...